Dermata Therapeutics, Inc. insider trading

DRMANASDAQ

$1.11-0.01 (-0.45%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-77.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

GTGerald T. ProehlPRESIDENT, CHAIRMAN, CEO9.2641%of company
KKKyri K. van HooseSVP, CFO5.7796%of company
MFMary FisherDirector0.4897%of company
DFDavid F. HaleDirector0.2026%of company
MMMunera Maria E. Bedoya-ToroSVP, Regulatory Affairs0.026%of company
KDKathleen D. ScottDirector0.00%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
DRMA	Kathleen D. ScottDirector	Open market sell$13.1	-91.7%	$1.19	$13.1	Jun 16, 2026	Jun 16, 2026
DRMA	Munera Maria E. Bedoya-ToroSVP, Regulatory Affairs	Open market purchase$1.27K	+2173.9%	$1.27	$1.27K	Feb 17, 2026	Mar 17, 2026

End of history · 2 transactions